Principal Investigator:
Suzanne Topalian, M.D.
Department:
Pathology
Our lab currently focuses on three areas of immunotherapy research: gaining a deeper knowledge of the biological underpinnings of human autoimmune response; discovering biomarkers that will help us identify which patients and tumor types are most likely to respond to various immune therapies; and developing immune-based treatment combinations that could deliver a more powerful anti-tumor response than monotherapies.
Research Areas: cancer, PD-1, melanoma, immunotherapy, cancer immunology